Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 9/2002

01-09-2002 | Article

A multi-centre, blinded international trial of the effect of A1 and A2 β-casein variants on diabetes incidence in two rodent models of spontaneous Type I diabetes

Authors: P. Beales, R. Elliott, S. Flohé, J. Hill, H. Kolb, P. Pozzilli, G.-S. Wang, H. Wasmuth, F. Scott

Published in: Diabetologia | Issue 9/2002

Login to get access
Metadata
Title
A multi-centre, blinded international trial of the effect of A1 and A2 β-casein variants on diabetes incidence in two rodent models of spontaneous Type I diabetes
Authors
P. Beales
R. Elliott
S. Flohé
J. Hill
H. Kolb
P. Pozzilli
G.-S. Wang
H. Wasmuth
F. Scott
Publication date
01-09-2002
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 9/2002
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-002-0898-2

Other articles of this Issue 9/2002

Diabetologia 9/2002 Go to the issue

Article

Rare variants identified in the HNF-4α β-cell-specific promoter and alternative exon 1 lack biological significance in maturity onset diabetes of the young and young onset Type II diabetes

Article

The effect of birth weight on glucose tolerance in pigs at 3 and 12 months of age

Article

Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice

Article

Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial

Article

Underestimation of D-glucose utilisation as judged from the conversion of D-[3-3H]glucose to 3HOH

Article

Improved metabolic disorders of insulin receptor-deficient mice by transgenic overexpression of glucokinase in the liver
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits